Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body’s own immune system to fight the disease, often sparing patients from the harsh side effects of chemotherapy. But its success may hinge on everyday medications people are taking during treatment. Nicholas DeVito, from the Duke University School of Medicine, joined Jeff Hamlin to discuss the commentary highlighted in the Journal of Clinical Oncology.